Publications by authors named "Guangsheng He"

Claim this Profile
S
Severe hemolysis flare of refractory autoimmune hemolytic anemia with positive complement component C3d responsive to Iptacopan with cyclophosphamide and prednisone: a case report.
Yawen Zhang, Yuemin Gong, Guangsheng He

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis.
Huimin Jin, Zhen Guo, Liying Zhu, Fei Huang, Yujie Wu, Guangsheng He, Wenyi Shen

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Haploidentical-Hematopoietic Stem Cell Transplantation Using Modified Post-Transplantation Cyclophosphamide and Eltrombopag Combined With Immunosuppression for the Treatment of Severe Aplastic Anemia.
Andie Fu, Mengyuan Li, Yizhou Peng, Bing Xu, Li Li, Shengyun Lin, Guangsheng He

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iptacopan for cold agglutinin disease: a case report with literature review.
Baozhi Fang, Hongbin Lu, Xiao Yu, Peng Wang, Yifei Zhou, Qiudan Shen, Guangsheng He

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of the clinical feature, myeloid neoplasm-related gene mutation profiles and T cell diversity acquired pure red cell aplasia.
Yuemin Gong, Xingxing Chai, Xiaoqing Liu, Yawen Zhang, Yue Li, Guangsheng He

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing factor 3b subunit 1 mutation patterns and prognostic implications in myelodysplastic syndromes, acute myeloid leukemia, and chronic lymphocytic leukemia: A retrospective study of 1691 cases.
Chun Qiao, Yi Xia, Zhen Guo, Liying Zhu, Yujie Wu, Wenyi Shen, Guangsheng He

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and influencing factors of immunosuppressive therapy for pure red cell aplasia: meta-analysis and systematic review.
Muyassar Yusup, GuangSheng He, YuTing Qin, Niluopaer Tuerxun, JianPing Hao

Ann Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and outcomes in large granular lymphocyte leukemia - associated pure red cell aplasia with STAT3 mutation.
Xiaoqing Liu, Xingxing Chai, Qingling Yu, Wei Wang, Qiqiang Long, Guangsheng He

Ann Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies.
Alexander Röth, Rong Fu, Guangsheng He, Hazzaa Alzahrani, Sheng-Chieh Chou, Yosr Hicheri, Phillip Scheinberg

Eur J Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study.
Xin Zhao, Jing Sun, Zhihua Zhang, Miao Chen, Tiejun Gong, Guangsheng He, Liansheng Zhang

Lancet Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining immunosuppressive therapy with low dosage eltrombopag in Chinese patients with severe aplastic anemia: mild aggravation of hepatic injury.
Xiaoyu Chen, Qingling Yu, ChengTao Qin, Yawen Zhang, Jingnan Sun, Guangsheng He

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study.
Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Aili He, Yuqing Chen, Guangsheng He, Cuiping Zheng, Chenghao Jin, Hewen Yin

Blood Cancer J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Alexander Röth, Guangsheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Roberta Demichelis-Gómez, Sammy Chebon

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib.
Yuemin Gong, Yue Li, Xiaoyu Chen, Hui Yang, Yawen Zhang, Guangsheng He

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag.
Ting Zhang, Qingling Yu, Xiaoyu Chen, Hui Yang, Yuemin Gong, Guangsheng He

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.
Yuemin Gong, Xinyu Zhang, Xiaoyu Chen, Hui Yang, Yawen Zhang, Guangsheng He

Ann Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KMT2A is targeted by miR-361-3p and modulates leukemia cell's abilities to proliferate, migrate and invade.
Dan Xu, Jinlong Jiang, Guangsheng He, Haixia Zhou, Chengfu Ji

Hematology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia.
Hong Chang, Guangsheng He, Rong Fu, Fei Li, Bing Han, Hemant Mittal

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world.
Ruixin Li, Ningling Wang, Xingxing Chai, Linhai Yang, Kangkang Liu, Hailong He, Shengyun Lin, Guangsheng He

Clin Exp Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Yi Zhang, Hu Zhou, Minghui Duan, Sujun Gao, Guangsheng He, Hewen Yin

Am J Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
Li-Qiang Wu, Li-Fang Huang, Hui Yang, Bao-Dong Ye, Jian-Ping Sheng, Sheng-Yun Lin, Guang-Sheng He

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hemolytic exacerbations of Chinese PNH patients infected SARS-CoV-2 Omicron.
Hui Yang, Xingxing Chai, Yuemin Gong, Xinyu Zhang, Lingling Wang, Xiaoyu Chen, Guangsheng He

Immun Inflamm Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic.
Yawen Zhang, Yao He, Suli Wang, Jingnan Sun, Jinsong Jia, Guangsheng He

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease.
Huaquan Wang, Guangsheng He, Jinsong Jia, Mengyuan Liu, Hui Liu

J Transl Int Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A real‑world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
Yuanyuan Jin, Ruixin Li, Shengyun Lin, Jinsong Jia, Yan Yang, Guangsheng He

Ann Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis